PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,504 | -12.9% | 4,066 | -9.0% | 0.04% | -10.4% |
| Q2 2023 | $80,978 | -42.3% | 4,469 | -15.3% | 0.05% | -37.7% |
| Q1 2023 | $140,421 | -0.5% | 5,279 | -27.7% | 0.08% | +4.1% |
| Q4 2022 | $141,167 | +96.1% | 7,303 | -28.6% | 0.07% | +131.2% |
| Q1 2022 | $72,000 | -50.7% | 10,224 | -5.6% | 0.03% | -41.8% |
| Q4 2021 | $146,000 | +33.9% | 10,827 | +67.4% | 0.06% | +14.6% |
| Q3 2021 | $109,000 | -44.9% | 6,466 | -4.9% | 0.05% | -40.7% |
| Q2 2021 | $198,000 | -54.1% | 6,799 | -37.9% | 0.08% | -55.5% |
| Q1 2021 | $431,000 | +76.6% | 10,950 | +1.8% | 0.18% | +80.2% |
| Q4 2020 | $244,000 | – | 10,759 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |